Experimental Hematology
Volume 34, Issue 11 , Pages 1522-1531 , November 2006

Chemotherapy disrupts activity of translational regulatory proteins in bone marrow stromal cells

  • Suzanne D. Clutter

      Affiliations

    • Department of Microbiology and Immunology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WVa., USA
    • ,
  • James E. Fortney

      Affiliations

    • Department of Pediatrics, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WVa., USA
    • ,
  • Laura F. Gibson

      Affiliations

    • Department of Microbiology and Immunology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WVa., USA
    • Department of Pediatrics, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WVa., USA
    • Blood and Marrow Transplant and Hematologic Malignancy Program, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WVa., USA
    • Corresponding Author InformationOffprint requests to: Laura F. Gibson, Ph.D., Department of Pediatrics, Health Sciences Center, West Virginia University, Box 9214, Morgantown, WV 26506

Received 4 May 2006 ,Revised 13 June 2006 ,Accepted 29 June 2006.

References 

  1. Gibson LF, Fortney J, Landreth KS, et al. Disruption of bone marrow stromal cell function by etoposide. Biol Blood Marrow Transplant. 1997;3:122–132
  2. Dittel BN, LeBien TW. Reduced expression of vascular cell adhesion molecule-1 on bone marrow stromal cells isolated from marrow transplant recipients correlates with a reduced capacity to support human B lymphopoiesis in vitro. Blood. 1995;86:2833–2841
  3. Gibson LF, Piktel D, Landreth KS. Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells. Blood. 1993;82:3005–3011
  4. Hall B, Fortney J, Gibson L. Human bone marrow stromal cell SDF-1 production is reduced following exposure to topoisomerase II inhibitors, etoposide or doxorubicin. Analyt Pharmacol. 2003;4:21–29
  5. del Canizo C, Lopez N, Caballero D, et al. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999;23:901–905
  6. Clutter SD, Fortney J, Gibson LF. MMP-2 is required for bone marrow stromal cell support of pro-B-cell chemotaxis. Exp Hematol. 2005;33:1192–1200
  7. Gallagher JT, Spooncer E, Dexter TM. Role of the cellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures. J Cell Sci. 1983;63:155–171
  8. Drzeniek Z, Siebertz B, Stocker G, et al. Proteoglycan synthesis in haematopoietic cells: isolation and characterization of heparan sulphate proteoglycans expressed by the bone-marrow stromal cell line MS-5. Biochem J. 1997;327(pt 2):473–480
  9. Roberts R, Gallagher J, Spooncer E, et al. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature. 1988;332:376–378
  10. Morris AJ, Turnbull JE, Riley GP, et al. Production of heparan sulphate proteoglycans by human bone marrow stromal cells. J Cell Sci. 1991;99(Pt 1):149–156
  11. Jo DY, Rafii S, Hamada T, et al. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest. 2000;105:101–111
  12. D'Apuzzo M, Rolink A, Loetscher M, et al. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur J Immunol. 1997;27:1788–1793
  13. Bradley JM, Kelley MJ, Rose A, et al. Signaling pathways used in trabecular matrix metalloproteinase response to mechanical stretch. Invest Ophthalmol Vis Sci. 2003;44:5174–5181
  14. Pause A, Belsham GJ, Gingras AC, et al. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature. 1994;371:762–767
  15. Morino S, Imataka H, Svitkin YV, et al. Eukaryotic translation initiation factor 4E (eIF4E) binding site and the middle one-third of eIF4GI constitute the core domain for cap-dependent translation, and the C-terminal one-third functions as a modulatory region. Mol Cell Biol. 2000;20:468–477
  16. Tee AR, Proud CG. DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling. Oncogene. 2000;19:3021–3031
  17. Jeffrey IW, Bushell M, Tilleray VJ, et al. Inhibition of protein synthesis in apoptosis: differential requirements by the tumor necrosis factor alpha family and a DNA-damaging agent for caspases and the double-stranded RNA-dependent protein kinase. Cancer Res. 2002;62:2272–2280
  18. Jefferies HB, Fumagalli S, Dennis PB, et al. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J. 1997;16:3693–3704
  19. Jefferies HB, Reinhard C, Kozma SC, et al. Rapamycin selectively represses translation of the “polypyrimidine tract” mRNA family. Proc Natl Acad Sci U S A. 1994;91:4441–4445
  20. Lin TA, Lawrence JC. Control of PHAS-I phosphorylation in 3T3-L1 adipocytes: effects of inhibiting protein phosphatases and the p70S6K signalling pathway. Diabetologia. 1997;40(Suppl 2):S18–S24
  21. Peterson RT, Desai BN, Hardwick JS, et al. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. Proc Natl Acad Sci U S A. 1999;96:4438–4442
  22. Lin TA, Kong X, Haystead TA, et al. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science. 1994;266:653–656
  23. Pullen N, Dennis PB, Andjelkovic M, et al. Phosphorylation and activation of p70s6k by PDK1. Science. 1998;279:707–710
  24. Sekulic A, Hudson CC, Homme JL, et al. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 2000;60:3504–3513
  25. Collins LS, Dorshkind K. A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J Immunol. 1987;138:1082–1087
  26. Gibson LF, Piktel D, Landreth KS. Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells. Blood. 1993;82:3005–3011
  27. Herzig S, Neumann J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev. 2000;80:173–210
  28. Meyuhas O. Synthesis of the translational apparatus is regulated at the translational level. Eur J Biochem. 2000;267:6321–6330
  29. Avni D, Biberman Y, Meyuhas O. The 5′ terminal oligopyrimidine tract confers translational control on TOP mRNAs in a cell type- and sequence context-dependent manner. Nucleic Acids Res. 1997;25:995–1001
  30. Kollet O, Dar A, Shivtiel S, et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med. 2006;12:657–664
  31. Ponomaryov T, Peled A, Petit I, et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest. 2000;106:1331–1339

PII: S0301-472X(06)00429-2

doi: 10.1016/j.exphem.2006.06.021

Experimental Hematology
Volume 34, Issue 11 , Pages 1522-1531 , November 2006

Article Tools

* Image Usage & Resolution